scispace - formally typeset
C

Chao Zhao

Researcher at Peking University

Publications -  28
Citations -  439

Chao Zhao is an academic researcher from Peking University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 9, co-authored 17 publications receiving 282 citations.

Papers
More filters
Journal ArticleDOI

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study

TL;DR: Although HPV18 appeared to be less frequent among population-based samples of China, given the high prevalence of HPV 16 and 18 in high-grade squamous intraepithelial lesion (HSIL) or worse pap abnormalities, prophylactic HPV16/18 vaccines should substantially reduce the burden of cervical cancer in China.
Journal ArticleDOI

Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients.

TL;DR: Oral progestin is an effective fertility-sparing treatment for women with CAH/G1EC in China and patients with elevated HbA1C receiving both metformin and progest in were more likely to achieve complete response (CR), whereas those with PCOS were not.
Journal ArticleDOI

Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.

TL;DR: TERC amplification represents a valuable genetic biomarker, which in combination with an evaluation of cytology or HPV testing, can achieve higher sensitivity and specificity in distinguishing high-grade cervical lesions and invasive cancers from low-grade lesions compared with conventional methods.
Journal ArticleDOI

Sorting and identification of side population cells in the human cervical cancer cell line HeLa.

TL;DR: SP cells possess some characteristics of CSCs, namely high proliferation ability, chemoresistance and radioresistance, which may be helpful to elucidate novel targets for effective clinical treatments of cervical cancer in the future.